UAE-based BioSapien extends its pre-Series A funding to over USD 8M, with new investor Globivest joining existing backers for its innovative MediChip™ platform.
Amount Raised
$8 Million
Round Type
Pre-Series A
Investors
Description
BioSapien has successfully extended its pre-Series A funding round to over USD 8 million, backed by MENA-based VC firm Globivest. The startup is focused on developing MediChip™, a localized cancer treatment platform. This extension adds to previous investments from Global Ventures, Golden Gate Ventures, and Dara Holdings. Notably, BioSapien aims to minimize systemic toxicity while delivering treatment directly to tumor sites.
Quick answer
BioSapien raised $8 Million in a Pre-Series A round, dated July 7, 2025. Investors: Dara Holdings, Golden Gate Ventures, Global Ventures and Globivest.
- How much did BioSapien raise?
- BioSapien raised $8 Million in a Pre-Series A round on July 7, 2025.
- Who invested in BioSapien?
- Dara Holdings, Golden Gate Ventures, Global Ventures and Globivest are named as investors in this round.
- What does BioSapien do?
- Biosapien is a late-stage pre clinical company focused on novel drug delivery platforms.
- Who are the decision-makers at BioSapien?
- Fundz holds 1 contact at BioSapien. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as BioSapien that raised within 45 days of this round, from Fundz verified event records.
- Retension Pharmaceuticals raised $15M (Series B) on August 6, 2025.
- Faeth Therapeutics raised $24M on August 1, 2025.
- Silexion Therapeutics raised $3.6M on August 1, 2025.
- Compugen raised $3.5M (Seed) on July 15, 2025.
- FELIQS raised $9M (Series A) on July 1, 2025.
- Pelthos Therapeutics raised $50M on July 1, 2025.
Who to call at BioSapien, and when
A new round usually means BioSapien is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BioSapien raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioSapien, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioSapien. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioSapien raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioSapien raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.